5HT2A modulation attenuates pancreatic cancer induced pain mouse model by inhibiting HDAC
Acta Cirúrgica Brasileira · 2024
DOI: 10.1590/acb392324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2024. Verfasst von Weiwei Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Gaoxin Hospital - Department of General Surgery - Xi'an - China. Hauptthemen laut MEDLINE: Cancer Pain, Neuralgia, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Xi'an Gaoxin Hospital - Department of General Surgery - Xi'an - China.
- ERA University - ERA College of Pharmacy - Department of Pharmacology - Lucknow - India.
Zitieren
APA
Fan, W., Yang, X., Zhou, L., Xu, J., Huang, W., & Tripathi, A. S. (2024). 5HT2A modulation attenuates pancreatic cancer induced pain mouse model by inhibiting HDAC. Acta Cirúrgica Brasileira. https://doi.org/10.1590/acb392324
Vancouver
Fan W, Yang X, Zhou L, Xu J, Huang W, Tripathi AS. 5HT2A modulation attenuates pancreatic cancer induced pain mouse model by inhibiting HDAC. Acta Cirúrgica Brasileira. 2024. doi:10.1590/acb392324
BibTeX
@article{Fan2024,
author = {Fan, Weiwei and Yang, Xijia and Zhou, Liang and Xu, Jianqing and Huang, Weihua and Tripathi, Alok Shiomurti},
title = {5HT2A modulation attenuates pancreatic cancer induced pain mouse model by inhibiting HDAC},
journal = {Acta Cirúrgica Brasileira},
year = {2024},
doi = {10.1590/acb392324}
}
EUVIMED